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Abstract 
 
The normal bacterial flora of an organism includes the non-disease causing bacteria that inhabit 
the human body under normal conditions. These bacteria are important for numerous reasons; for 
example, they excrete vitamins and prevent colonization by pathogens. Autism spectrum disorders 
(ASDs) are neurodevelopmental disorders that are characterized by social challenges, repetitive 
behaviors, and communication deficits. Comorbid conditions including gastrointestinal (GI) 
issues, depression, and anxiety are common. One popular way to attempt to alleviate the behavioral 
symptoms of ASDs is maintaining a ketogenic diet, which is seventy-five percent fat. Such a diet 
induces ketosis, a metabolic state when ketone bodies, not glucose, are used as the primary fuel. 
This study analyzes how the ketogenic diet affects the GI flora in a mouse model of ASDs and 
aims to determine if the benefits of a ketogenic diet are correlated with changes in the gut flora. In 
order to determine the types of bacteria present, the 16s rRNA gene was amplified from the fecal 
samples of mice in treatment groups.  The amplified DNA was then digested with a restriction 
enzyme (HaeIII) and Terminal Restriction Fragment Length Polymorphism (TRFLP) 
electropherograms were generated. Analyses of the electropherograms suggest there is no 
significant difference in number of species present or abundance of bacteria between any pre and 
post diet conditions, except for the normal mouse on a ketogenic diet. Additionally, there are 28 
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Introduction  
 
Autism spectrum disorders (ASDs) are neurodevelopmental disorders that affect about 1 
in 68 American children (Autism Spectrum Disorders, n.d.). They are defined by three main 
symptoms: social challenges, repetitive behaviors, and communication deficits. For example, a 
person on the autism spectrum could have limited verbal skills or have trouble maintaining eye 
contact (Autism Spectrum Disorders, n.d.). People on the autism spectrum have a wide range of 
cognitive impairments and varying levels of disability, causing treatments for ASDs to be unique 
for each individual. They can include behavioral therapy and/or medications targeted to improve 
a variety of “comorbid conditions,” such as anxiety, depression, seizures, and gastrointestinal 
(GI) issues (“How Is Autism Treated,” n.d.). There seems to be a link between ASDs and the 
ketogenic diet, and between ASDs and gut microbiota. This study investigates if there are 
differences in the gut microbiome of a mouse model of ASDs on a normal diet compared to a 
mouse model of ASDs on a ketogenic diet, and compares them to normal mice on a normal diet 
and normal mice on a ketogenic diet.  
In people with ASDs, GI disorders are among the most common, including chronic 
diarrhea, constipation, and irritable bowel conditions. The Center for Disease Control (CDC) 
found that children with ASDs are 3.5 times more likely to develop GI issues than their normally 
developing peers (Schieve et al., 2012). The increased discomfort and pain from GI problems 
can exacerbate other behavioral ASD symptoms (Autism and GI Disorders, n.d.). According to 
surveys, as many as 40 percent of children with autism have been placed on special diets at one 
point in their life in hopes of alleviating their behavioral symptoms. The ketogenic diet, in which 
seventy-five percent of calories come from fat, induces ketosis, a metabolic state when ketone 
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bodies, not glucose, are used as the primary fuel. Such a diet is a popular choice for ASDs and 
has recorded benefits for treatment of epilepsy (Alpert, 2007).  
For generations, an association between metabolism and brain function has been evident. 
Even in ancient times, epileptic seizures were treated by fasting. The ketogenic diet serves as an 
effective treatment for epilepsy because it mimics the conditions of starvation, without the lack 
of all nutrients, merely the lack of carbohydrates. Instead of getting fuel from carbohydrates like 
glucose, the body receives it from ketone bodies (Wilder, 1921). During limited carbohydrate 
intake, such as fasting or the ketogenic diet, the liver increases production of the ketone bodies, 
acetoacetate, acetone, and -hydroxybutyrate, that get released to generate adenosine 
triphosphate (ATP) throughout the body (Aoki, 1981).  
Studies have found that in humans, the ketogenic diet is correlated to the functions of the 
central nervous system (CNS). It can decrease anxiety and even improve symptoms of ASDs 
(Brinkworth et al., 2009). One pilot study evaluated children with ASDs who maintained a 
ketogenic diet by using the Childhood Autism Rating Scale. Significant improvement was 
reported for 11% of children, average improvement for 44%, and mild improvement for 44%. 
Interestingly, the most improvements were seen in children exhibiting mild autistic behavior 
(Evangeliou et al., 2003).  
Many studies use the inbred BTBR T+ tf/j (BTBR) strain of mice as a model for ASDs 
because they have been characterized as having an autism-like phenotype. BTBR mice share the 
same core traits as ASDs, and even some minor traits, such as selective food preference 
(McFarlane et al., 2007). BTBR mice are widely accepted as a mouse model of ASDs and were 
used in a study by Ruskin et al. (2015) which confirmed that the BTBR mice have low 
sociability, increased repetitive behavior, and reduced communication compared to other strains 
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exhibiting normal behaviors. The study analyzed how these symptoms were effected by a 
ketogenic diet, and the results showed the ketogenic diet improved the behavioral symptoms 
significantly. This study by Ruskin et al. (2015) was groundbreaking because it was the first time 
a diet showed significant behavioral benefits in a mouse model of ASDs.  
Modifying diet can affect neurological disorders, whether ASDs or epilepsy, due to the 
gut-brain axis (GBA), a term commonly used to describe the bidirectional communication 
system that exists between the CNS and the gut (Grenham et al., 2011). One study by Sudo et al. 
(2004) used germ-free (GF) mice to examine how the intestinal microbiome influences the CNS, 
showing that colonization of the gut by normal flora must occur to ensure normal development 
of the hypothalamic-pituitary-adrenal (HPA) axis, which is responsible for regulating many 
processes, ranging from digestion to stress. The same study revealed a decrease in brain derived 
neurotrophic factor (BDNF), a neurotrophin related to neuronal growth and survival, in mice 
whose normal flora were never established fully (Sudo et al., 2004).  
Some studies have examined the opposing direction of influence- how the brain impacts 
the gut microbiome. Kiliaan et al. (1998) confirmed that stress induces permeability of the gut, 
allowing certain bacteria to enter, in turn activating an immune response which then changes the 
composition of the intestinal microbiome. Another study on rhesus monkeys looked at maternal 
separation, an early life stressor. The fecal bacteria were analyzed to measure gut microbiota, 
and by day 3 post separation there was a significant decrease in Lactobacilli (Bailey and Coe, 
1999). A study by O’Mahony et al. (2009) analyzed the long term effects of maternal separation 
in rats and found a significantly altered gut microbiome when compared to the non-separated 
control group.  
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Numerous mechanisms of action have been proposed to explain how the GBA works, 
including both neural and humoral routes. One study identified the vagus nerve, a major part of 
the parasympathetic nervous system, which unconsciously controls the digestive tract, as the key 
communication pathway between the gut and the CNS (Bravo et al., 2011). Bravo et al. (2011) 
found that mice whose vagus nerve was surgically cut did not show the same neurochemical or 
behavioral effects as control mice when subjected to a variety of stressors. Other mechanisms 
could be related to modulation of systemic tryptophan levels (Grenham et al., 2011). 
Many studies examine the bacterial flora of the gut to learn about the CNS and the GBA. 
The normal bacterial flora of an organism includes the non-disease causing bacteria that inhabit 
the human body under normal conditions. These bacteria are important for numerous reasons, 
including metabolic and protective functions. Escherichia coli excrete metabolites such as 
vitamin K, which is necessary for blood clotting, but not made by the human body (Davis, 1996). 
The normal flora also prevents colonization by pathogens by occupying space in the 
gastrointestinal tract, making it unavailable to disease causing pathogens (Davis, 1996). 
Development of the innate immune system, which helps initially distinguish potential pathogens 
from harmless microbes, is influenced by ligands of the normal flora, including 
lipopolysaccharide and lipoteichoic acid (Grenham et al., 2011).  
The gut is inhabited by about 1014 microorganisms, which is more than 10 times the 
number of human cells in our entire body (Davis, 1996). During the postnatal period, after 
leaving the sterile uterine environment, facultative bacteria begin colonization of the gut. Next, 
the gram positive bacteria colonize via breast feeding and then gram negative bacteria alter the 
flora when the baby expands types of foods in its diet (Davis, 1996). Eventually, the normal 
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balance of flora is established, creating a stable, adult-like signature, which can be altered by 
infection, disease, diet, and antibiotics (Grenham et al., 2011).  
Bacterial flora that is normal in one area of the body can be pathogenic in a different 
location (Davis, 1996). For example, species of Streptococcus can be commensal in an oral 
habitat, but become pathogenic in artificial joints after arriving via the bloodstream. Similarly, 
during birth through the vaginal canal, neonates can uptake Streptococcus that can travel to the 
respiratory tract and result in bacterial meningitis.  
Knowledge of the normal flora increased substantially when germ-free (GF) animals 
became available for studies. GF animals are obtained by surgical delivery and then raised in a 
sterile environment, which hinders the acquisition of normal flora (Davis, 1996). These GF 
animals serve as comparison for animals that are exposed to normal flora during their lifetime. 
Studies using GF animals helped bridge the gap in the knowledge of the intestinal microbiome, 
eventually enabling scientists to determine that the gut contains a high abundance of the phyla 
Bacteroidetes and Firmicutes, and a lower abundance of Proteobacteria, Actinobacteria, 
Fusobacteria, and Verrucomicrobia (Eckburg et al., 2005). Also, following meals, the gut flora 
is highest, while after digestion, it is frequently undetectable (Davis, 1996). 
Many diseases have shown an association with the intestinal microbiome. Often, 
instances of stress and disease are bidirectionally linked to abnormal gut function and flora, 
while a healthy status is related to normal gut physiology and flora (Grenham et al., 2011). A 
study conducted by Backhed et al. (2007) analyzed a potential microbial basis for obesity, in 
addition to the many other factors contributing to the disease. Researchers took GF mice and 
colonized their GI tract with fecal flora. The resulting weight gain supported evidence of the 
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connection between the microbiome and disease, which can be applied to other diseases where 
the gut flora is known to be abnormal.  
Not only have patients with ASDs shown increased GI problems, they have exhibited 
differences in the gut microbiota. Increased amounts of Clostridium were seen in the guts of 
patients with ASDs (Song et al., 2004). One study found that due to the presence of increased 
toxin producing bacteria, ASDs could worsen (Parracho et al., 2005). The same study by 
Parracho et al. (2005) observed Sutterella and Clostridium bolteae in ASD patients with GI 
issues, but not in control populations with similar GI problems. Another study discovered lower 
levels of Bifidobacterium and higher levels of Lactobacillus in children with ASDs (Finegold et 
al., 2010). Also, in patients with ASDs, increased gut permeability has been correlated with 
progression of the disease most likely due to an escape of microbes and cytokines into the blood 
stream (Turner, 2009). 
Sandler et al. (2000) found that the antibiotic vancomycin was effective at normalizing 
the intestinal microbiome and improving symptoms. The study did not recommend their protocol 
as a treatment for ASDs, but it did support a relationship between the intestinal microbiota and 
CNS. Martin et al. (2008) saw a significant increase in Bifidobacterium and Bacteroides 
distasonis and a significant decrease in E. coli and Clostridium perfringens when patients were 
provided prebiotics. Antibiotics, prebiotics, and probiotics are promising potential treatments for 
gut microbiome related diseases, however more research needs to be completed (Grenham et al., 
2011). Fecal transplants are another potential treatment option because they help re-establish the 
normal gut flora. They have been successful in laboratory animals and in certain human cases, 
but still need more research to be fully understood (Petrof and Khoruts, 2014).  
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Previous studies have presented two major concepts: that the ketogenic diet improves 
ASD symptoms via the GBA, and that ASDs are associated with changes in the gut microbiome 
that affect disease progression via the GBA. This exploratory study combines these two ideas in 
order to examine the effects that the ketogenic diet has on the gut microbiota in BTBR mice. 
More specifically, this study aims to determine if there is a difference in the number of bacterial 
species present or the overall abundance of bacteria in the gut on and off a ketogenic diet. This 
study also explores the possibility of improved ASD symptoms being attributed to changes in gut 
microbiota. Additionally, the bacterial population similarities between treatment groups (Normal 
Mouse, BTBR Mouse, Normal Diet, and Ketogenic Diet) are analyzed to identify potentially 
significant species that should be investigated further via DNA sequencing.  
After the most of the data had been collected for this study, Klein et al. published a paper 
exploring how the ketogenic diet affects the gut microbiome in BTBR mice (2016). They kept 
the mice on a normal diet or placed them on a ketogenic diet at 5 weeks of age. Two weeks later, 
feces were collected and the mice were sacrificed. DNA was extracted from the samples, 
quantitative PCR was conducted to amplify the 16s rRNA gene, and microbial profiling was 
completed to identify the bacterial species present and their abundances. Klein et al. found that 
the ketogenic diet significantly reduced total microbe numbers and that diet, rather than mouse 
type, was the main driver of microbial changes. Because this study was published, the results of 
our study can be compared directly to the study by Klein et al.  
 Our experimental parameters relied on previously successful and widely accepted 
techniques for exploring individual bacterial species in a population. The 16s rRNA gene is 
highly conserved in different bacterial species, but has a number of hyper-variable regions that 
can enable identification of specific species via sequencing (Kolbert and Persing, 1999). In this 
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study, DNA was isolated from fecal samples, the 16s rRNA gene was amplified using PCR, and 
Terminal Restriction Fragment Length Polymorphism (TRFLP) analysis was conducted to 
determine the flora present in the intestinal microbiota. TRFLP analysis has been successfully 
used to identify flora extracted from feces, further supporting the experimental design of this 
study (Hayashi et al., 2005).  
 
 
Figure 1. Pictorial representation of the study goals 
 
Materials and Methods 
Obtaining Fecal Samples 
Fecal samples were obtained from 5-week old normal mice on a normal diet, normal 
mice on a ketogenic diet, BTBR mice on a normal diet, and BTBR mice on a ketogenic diet 
(collected from Dr. Masino’s lab, n = 6, 9, 16, 13 respectively). When mice were removed from 
the diet at 8 weeks of age, another fecal sample was taken (n = 6, 8, 16, 12). All samples were 
coded to prevent bias and stored in the -80C freezer until DNA was isolated.  
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DNA Isolation 
DNA was isolated from 88 samples using the MO BIO PowerFecal® DNA Isolation Kit. 
The Trinity College Biology Department’s NanoDrop was then used to quantify the amount of 
DNA.  
Polymerase Chain Reaction (PCR) with labeled primers  
To amplify the 16s rRNA gene, PCR was performed on each fecal sample. Two 
fluorescently labeled (FAM, HEX) universal primers that have been identified to amplify the 16s 
rRNA gene across bacterial species were used (Kuramae et al., 2010; Baker et al., 2003). The 
forward primer was 27F-FAM [5’-(6FAM)AGAGTTTGATCCTGGCTCAG-3’] and the reverse 
primer was 926R-HEX [5’-(HEX)CCGTCAATTCMTTTRAGTTT-3’]. Samples were placed in 
the thermocycler with settings for 95C initial denaturation, 50C primer annealing, and 72C 
extension for 35 cycles. The results were checked on a 0.8% agarose gel. 
Restriction Digests 
All 88 amplified samples were digested with the restriction enzyme HaeIII at 37C for 
two to three hours. A 1.2% agarose gel was used to confirm digestion of the samples. 
Purification 
Restriction digest fragments were purified based on the procedure outlined in the 
QIAquick® Spin Handbook titled “QIAquick PCR Purification Kit Protocol Using a 
Microcentrifuge.” A 1.2% agarose gel was run to check purification.  
Terminal Restriction Fragment Length Polymorphism (TRFLP) Analysis  
Purified fragments from each restriction digest were diluted using highly deionized 
formaldehyde (HDF) to two concentrations. The high concentration was 7 µl sample to 3 µl of 
HDF and the low concentration was 5 µl sample to 5 µl HDF. A plate of samples was sent to 
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Yale University where each sample underwent fragment analysis. GeneMarker® was used to 
analyze the electropherograms and extract peak heights to determine overall abundance of 
bacteria, number of peaks per sample to determine the number of species, and peak sizes.  
Determination of Common, Unidentified Species 
 Sample peak sizes were compared to determine which species were common between 
two or more of the experimental groups.  
Statistical Analyses 
T-tests were conducted to compare the means of the samples from 5 week old mice and 
the samples from 8 week old mice. More specifically, P-values calculated in Microsoft Excel 
determined the statistical significance (95% confidence) between the number of species present 
at 5 weeks of age and 8 weeks of age, and between the overall abundance of bacteria at 5 weeks 
of age and 8 weeks of age. Two-way Analysis of Variance (ANOVA) was used to compare the 
means of the overall abundance of bacteria in the four experimental conditions in the samples 
from 8 week old mice.   
Results 
Similarities Between the Four Experimental Groups 
 There were twenty-eight unidentified bacterial species (A-BB) that were common 
between two or more of the experimental groups, based on the comparison of sample peak sizes 
(Table 1). There were ten bacterial species found in all four of the sample groups; nine species 
found in only the normal mouse and normal diet groups; five species found in the BTBR mouse 
sample and both diet samples; one species found in the BTBR mouse strain and the ketogenic 
diet samples; one species found in both the normal and BTBR mouse strain and the normal diet; 
and one species found in the BTBR strain and normal diet sample groups (Figure 1). 
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Table 1.  Associated peak size ranges for the 28 unidentified bacterial species (A-BB) that were 
common between two or more of the experimental groups. 
 
 
Figure 1. Pictorial representation of the 28 unidentified bacterial species (A-BB) and their 
respective experimental groups. Each species is distinguished by a unique peak size. 
 
M
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Number of Bacterial Species Present  
 A significant increase was seen between the number of bacterial species found in a 
normal mouse before and after a ketogenic diet (P=0.003; Figure 2). No significant difference 
was seen between the number of bacterial species pre and post diet in the normal mouse on a 
normal diet (P=0.224), BTBR mouse on a normal diet (P=0.199), and BTBR mouse on a 
ketogenic diet (P=0.113; Figure 2). 
  
Figure 2. Number of bacterial species present in the four experimental groups (normal mouse on 
a normal diet, BTBR mouse on a normal diet, BTBR mouse on a ketogenic diet, and normal 
mouse on a ketogenic diet) before and after a ketogenic or normal diet. Blue bars represent 
samples taken before mice were put on a ketogenic diet or kept on a normal diet. Red bars 
represent samples taken three weeks later. Respective n values are shown on each bar. Error bars 
represent standard error of the mean.  
Overall Abundance of Bacteria 
A significant increase was seen between the overall abundance of bacteria found in the 
normal mouse before and after a ketogenic diet (P=0.003; Figure 3). No significant difference 
was seen between the overall abundance of bacteria pre and post diet in the normal mouse on a 
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normal diet (P=0.334), BTBR mouse on a normal diet (P=0.632), and BTBR mouse on a 
ketogenic diet (P=0.097; Figure 3). 
  
Figure 3. Overall abundance of bacteria present in the four experimental groups (normal mouse 
on a normal diet, BTBR mouse on a normal diet, BTBR mouse on a ketogenic diet, and normal 
mouse on a ketogenic diet) before and after a ketogenic or normal diet. Blue bars represent 
samples taken before mice were put on a ketogenic diet or kept on a normal diet. Red bars 
represent samples taken three weeks later. Respective n values are shown on each bar. Error bars 
represent standard error of the mean. 
Two-Way ANOVA for Comparison to Klein et al. 2016 
 The two-way ANOVA showed no significant difference between the ketogenic diet and 
the normal diet (P=0.8243) and between the normal mouse and the BTBR mouse (P=0.3031). No 
significant relationship was seen between diet and mouse type, either (P=0.7104).  
Discussion 
Similarities Between the Four Experimental Groups 
There were twenty-eight unidentified bacterial species (A-BB) that were common 
between two or more of the experimental groups, based on the comparison of sample peak sizes 
GUT FLORA IN A MOUSE MODEL OF ASDs ON A KETOGENIC DIET  18 
(Table 1; Figure 1). By looking at which unidentified species are present in which groups, 
species that are potentially significant for diagnosis or treatment can be identified.  
For example, species M, A, E, H, I, and S are all potential biomarkers of ASDs. Species 
M is only found in the normal mouse, regardless of diet. Its absence could be a biomarker of 
ASDs because species M is not found in the BTBR mouse. Conversely, species A, E, H, I, and S 
can also be biomarkers of ASDs because they are only present in the BTBR mouse.  
Species D, G, and X provide insight about potential therapies of ASDs. Species D is only 
present in the BTBR mouse on the ketogenic diet. The presence of species D could help explain 
the improvements in behavioral symptoms seen in mouse models of ASDs on the ketogenic diet 
(Ruskin et al., 2015). It is possible that supplementing species D into a normal diet via a 
probiotic could improve the behavioral symptoms of ASDs. Both species G and species X are 
eliminated by the ketogenic diet. Species G is only found in the BTBR mouse on the normal diet. 
Species X is present in both mouse types on the normal diet, but not on the ketogenic diet. 
Species G might have harmful effects on the BTBR mouse because improvements in behavioral 
symptoms are seen in the mice lacking species G, the BTBR mice on the ketogenic diet. 
Eliminating these species could be another target for ASDs treatment. Future studies should 
sequence the significant, unidentified species in order to identify and learn more about them.  
Number of Bacterial Species Present and Overall Abundance of Bacteria 
 No significant difference was seen between the number of bacterial species present pre 
and post diet in the normal mouse on a normal diet (P=0.224), BTBR mouse on a normal diet 
(P=0.199), and BTBR mouse on a ketogenic diet (P=0.113; Figure 2). No significant difference 
was seen between the overall abundance of bacteria pre and post diet in the normal mouse on a 
normal diet (P=0.334), BTBR mouse on a normal diet (P=0.632), and BTBR mouse on a 
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ketogenic diet (P=0.097; Figure 3). However, a general trend of increase is seen when comparing 
the before diet data to the after diet data, which can be attributed to the establishment and 
increase of normal flora as the mice age.  
Both the significant differences seen between the number of bacterial species found and 
between the overall abundance of bacteria found in a normal mouse on a ketogenic diet pre and 
post diet are questionable. The number of bacterial species found in a normal mouse that has not 
yet been put on a normal diet is expected to be similar to the the number of bacterial species 
found in a normal mouse that has not yet been put on a ketogenic diet. Similarly, the overall 
abundance of bacteria found in a normal mouse that has not yet been put on a normal diet is 
expected to be similar to the overall abundance of bacteria found in a normal mouse that has not 
yet been put on a ketogenic diet. Up to that point, both groups had the same treatment, therefore, 
it is expected they would have similar numbers of bacterial species present and similar overall 
abundances of bacteria (Figure 2, Figure 3). 
It is plausible that if the normal mouse on a ketogenic diet had more species present (like 
the normal mouse on a normal diet) that there would no longer be a statistically significant 
difference between the pre and post diet groups. It is also possible that if the normal mouse on a 
normal diet had fewer species present (like the normal mouse on the ketogenic diet) that there 
would be a significant difference between the pre and post diet groups for the normal mouse on 
the ketogenic diet. If both normal mouse groups had a significant difference between pre and 
post diet conditions, one conclusion could be that the normal mouse might not have established 
their baseline level of the number of bacterial species in their guts at the pre diet stage.  This 
same concept can be applied to the overall abundance of bacteria results, as well.  
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Future studies should increase the sample sizes to validate the results from this study. 
Additionally, other studies could put the mice on either the ketogenic diet or normal diet when 
the mice are older, in order to control for the possibility that normal mice might not have 
established their baseline level of the number of bacterial species and/or overall abundance of 
bacteria in their guts at the pre diet stage.  
Comparison to Klein et al. 2016 
 In our study, a two-way ANOVA was used to obtain information on the overall 
abundance of bacteria data that could be compared to the study by Klein et al. (2016). This two-
way ANOVA showed no significant difference between the ketogenic diet and the normal diet 
(P=0.8243) and between the normal mouse and the BTBR mouse (P=0.3031). No significant 
interaction was seen between diet and mouse type, either (P=0.7104). However, Klein et al. 
(2016) found that the ketogenic diet significantly reduced total microbe numbers and that diet, 
rather than mouse type, was the main driver of microbial changes.  
Despite having similar experimental set ups, our study and Klein et al.’s study had 
different results. Our study had slightly larger sample sizes, our mice were on the diet for three 
weeks, and we used qualitative PCR. Klein et al.’s study had their mice on the diet for two weeks 
and used quantitative PCR. However, none of these differences can fully explain the 
discrepancies in the results. The major difference between the studies and one possible 
explanation for the differences is that we used TRFLP analysis and Klein et al. used microbial 
profiling, which is more sensitive. Microbial profiling uses next-generation sequencing and 
compares its information to a known database, while TRFLP merely identifies a peaks from 
unknown bacteria. Future studies should repeat this experiment using the more accurate method 
of microbial profiling in order to validate the results seen in our study and Klein et al.’s.  
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Conclusion 
There were twenty-eight unidentified bacterial species (A-BB) found to be common 
between two or more experimental groups. Also, there was a significant difference (P=0.003) in 
the number of bacterial species and in the overall abundance of bacteria in the normal mouse 
before and after a ketogenic diet. Lastly, Klein et al. (2016) found diet to be the driver of 
microbial changes, while our study could not identify a source of microbial changes. 
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